RAPT Therapeutics (RAPT) Shares Outstanding (Diluted Average) (2021 - 2024)
Historic Shares Outstanding (Diluted Average) for Therapeutics (RAPT) over the last 4 years, with Q3 2024 value amounting to $38.9 million.
- Therapeutics' Shares Outstanding (Diluted Average) rose 142.2% to $38.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $38.9 million, marking a year-over-year increase of 142.2%. This contributed to the annual value of $38.3 million for FY2023, which is 1781.71% up from last year.
- Per Therapeutics' latest filing, its Shares Outstanding (Diluted Average) stood at $38.9 million for Q3 2024, which was up 142.2% from $38.9 million recorded in Q2 2024.
- In the past 5 years, Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $38.9 million in Q3 2024 and a low of $25.6 million during Q2 2021
- Moreover, its 4-year median value for Shares Outstanding (Diluted Average) was $36.0 million (2022), whereas its average is $34.2 million.
- Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first skyrocketed by 2944.66% in 2023, then soared by 90.08% in 2024.
- Quarter analysis of 4 years shows Therapeutics' Shares Outstanding (Diluted Average) stood at $27.4 million in 2021, then grew by 18.8% to $32.5 million in 2022, then increased by 17.82% to $38.3 million in 2023, then increased by 1.47% to $38.9 million in 2024.
- Its Shares Outstanding (Diluted Average) was $38.9 million in Q3 2024, compared to $38.9 million in Q2 2024 and $38.6 million in Q1 2024.